Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

RANDOMIZED, DOUBLE-BLIND AND CONTROLLED WITH PLACEBO CLINICAL TRIAL, TO ASSESS THE EFFICACY AND TOLERABILITY OF COMBINATION OF SOY ISOFLAVONES AND EXTRACT OF RED CLOVER (FITOGYN) IN THE TREATMENT OF HOT FLASHES IN MENOPAUSAL WOMEN

Next Previous
Trial Profile

RANDOMIZED, DOUBLE-BLIND AND CONTROLLED WITH PLACEBO CLINICAL TRIAL, TO ASSESS THE EFFICACY AND TOLERABILITY OF COMBINATION OF SOY ISOFLAVONES AND EXTRACT OF RED CLOVER (FITOGYN) IN THE TREATMENT OF HOT FLASHES IN MENOPAUSAL WOMEN

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Herbal medicines; Isoflavone/soybean protein
  • Indications Hot flashes; Menopause; Vasomotor symptoms
  • Focus Therapeutic Use

Most Recent Events

  • 28 Sep 2011 Biomarkers information updated
  • 27 Sep 2011 Planned end date (Jul 2012) added as reported by ClinicalTrials.gov.
  • 27 Sep 2011 Last checked against ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top